Hydralazine is a drug used as anti-hypertensive, and recently reported to be a DNA methylation inhibitor able to demethylate and reactivate the expression of tumor suppressor genes in cancer. The aim of the present study was to explore the potential mechanism by which hydralazine inhibits DNA methylation. For this purpose, we assessed the structural and electronic properties between 1-hydrazinophthalazine (hydralazine) and a putative ligand methyltransferase.
Keywords: docking, hydralazine, dna methyltransferase, dna methylation inhibitor, tumor suppressor gene
Rights & PermissionsPrintExport
Published on: 01 March, 2012
Page: [282 - 286]